SKI Market

A+| A| A-|

Indian Indices

Sensex

78,111.24 1,263.67
( 1.64%)

Global Indices

Nasdaq

48,558.84 319.59
(0.66%)

Dow Jones

6,987.77 80.53
(1.17%)

Hang Seng

58,133.63 256.24
(0.44%)

Nikkei 225

10,572.50 -36.56
(-0.34%)

Forex

USD-INR

93.84 0.69
(0.74%)

EUR-INR

109.88 0.75
(0.69%)

GBP-INR

126.18 0.90
(0.72%)

JPY-INR

0.59 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

21.36

97846.71

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.32

Back

cipla ltd

Cipla consolidated net profit declines 56.97% in the December 2025 quarter

Jan 23,2026

Net profit of Cipla declined 56.97% to Rs 675.80 crore in the quarter ended December 2025 as against Rs 1570.51 crore during the previous quarter ended December 2024. Sales rose 0.02% to Rs 6962.97 crore in the quarter ended December 2025 as against Rs 6961.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	6962.97	6961.60	0
OPM %	18.02	28.57	-
PBDT	1447.37	2195.89	-34
PBT	1169.02	1916.09	-39
NP	675.80	1570.51	-57

78,111.24 1,263.67 ( 1.64%)

48,558.84 319.59 (0.66%)

6,987.77 80.53 (1.17%)

58,133.63 256.24 (0.44%)

10,572.50 -36.56 (-0.34%)

93.84 0.69 (0.74%)

109.88 0.75 (0.69%)

126.18 0.90 (0.72%)

0.59 0.00 (0.59%)